Osaka-Based Kaneka Establishes Transdermal JV With Medrx
This article was originally published in PharmAsia News
Executive Summary
Osaka-based chemical and industrial conglomerate Kaneka and Kagawa Prefecture drug discovery firm Medrx established a joint venture to research, develop and manufacture therapeutic transdermal drugs